Literature DB >> 9683106

All adverse events in autologous blood donors with cardiac disease are not necessarily caused by blood donation.

S M Kasper1, J Ellering, P Stachwitz, J Lynch, R Grunenberg, W Buzello.   

Abstract

BACKGROUND: Autologous blood donation before elective cardiac surgery has become a standard of care at many institutions. However, the safety of autologous blood donations by patients with cardiac disease is subject to controversy. CASE REPORTS: Two life-threatening cardiac arrests and one fatal myocardial infarction that occurred in three patients who were scheduled to donate blood for autologous use in elective cardiac surgery are reported. All three patients met the institution's selection criteria for autologous blood donors, and all of them had given written informed consent for their participation in the autologous blood donation program. One of the two cardiac arrests and the myocardial infarction occurred in the patients prior to any blood donations, and the other cardiac arrest occurred 7 days after the patient donated blood uneventfully.
CONCLUSION: Life-threatening and fatal adverse events may occur during the donation period in autologous blood donors with cardiac disease. Not all adverse events are necessarily caused by blood donation.

Entities:  

Mesh:

Year:  1998        PMID: 9683106     DOI: 10.1046/j.1537-2995.1998.38798346636.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  2 in total

1.  Advantage of autologous blood transfusion in surgery for hepatocellular carcinoma.

Authors:  Yoshito Tomimaru; Hidetoshi Eguchi; Shigeru Marubashi; Hiroshi Wada; Shogo Kobayashi; Masahiro Tanemura; Koji Umeshita; Yuichiro Doki; Masaki Mori; Hiroaki Nagano
Journal:  World J Gastroenterol       Date:  2011-08-28       Impact factor: 5.742

2.  Necessity for autologous blood storage and transfusion in patients undergoing pancreatoduodenectomy.

Authors:  Yoshito Tomimaru; Kozo Noguchi; Keizo Dono
Journal:  Surg Today       Date:  2016-08-22       Impact factor: 2.549

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.